Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Pharmacology is Scopus-indexed (Q1, CiteScore 9.5), WoS SCIE, DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 1663-9812Verify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 26 / 278 | 90th | Q1 |
| Pharmacology | 42 / 328 | 87th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 9.5.
Frontiers in Pharmacology is Q1 in Pharmacology (medical) (rank 26 of 278) and Q1 in Pharmacology (rank 42 of 328), by CiteScore 2025.
Frontiers in Pharmacology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.5, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.248, quartile Q1, with an H-index of 203.
The publisher lists an article processing charge of about US$3,801 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Pharmacology is published by Frontiers Media SA. Its ISSN is 1663-9812.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Pharmacology has an h-index of 242 and a 2-year mean of 5.04 citations per paper (OpenAlex). Its Scopus CiteScore is 9.5, quartile Q1. On 2-year citations it ranks #24 of 271 Scopus journals in Pharmacology (medical).
Frontiers in Pharmacology published 4,127 papers in 2025; its busiest recent year was 2022 with 5,823. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (59.6%), United States (8.3%) and Italy (3.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 94 retracted papers are recorded (2.9 per 1,000 papers). The Problematic Paper Screener flags 3 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.